Status:
COMPLETED
Comparison of CABG Related Bleeding Complications in Patients Treated With Ticagrelor or Clopidogrel
Lead Sponsor:
Ajou University School of Medicine
Conditions:
Blood Loss, Surgical
Ticagrelor
Eligibility:
All Genders
19+ years
Brief Summary
In patients with coronary artery disease, dual antiplatelet therapy (acetylsalicylic acid and a P2Y12-receptor antagonist) is a commonly used method because of its excellent antithrombotic effect. In ...
Eligibility Criteria
Inclusion
- The patient with acute myocardial infarction received loading dose of clopidogrel or ticagrelor for coronary angiography within 2 days prior to emergency OPCAB or CABG.
Exclusion
- heart surgery combined with other operation (valve surgery, aorta surgery, trauma surgery)
- History of coagulopathy
- History of liver cirrhosis
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 6 2020
Estimated Enrollment :
1097 Patients enrolled
Trial Details
Trial ID
NCT04431349
Start Date
January 1 2016
End Date
May 6 2020
Last Update
June 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ajou University Hospital
Suwon, Gyeonggido, South Korea